Skip to main content
. Author manuscript; available in PMC: 2024 May 24.
Published in final edited form as: J Int Assoc Provid AIDS Care. 2017 Oct 11;16(6):603–607. doi: 10.1177/2325957417732835

Table 2.

Pre- and PostNavigation Comparisons.a

PreNavigation
n (%)
PostNavigation
n (%)
N = 84
P Value
HIV-1 RNA, copies/mL .03
 <40 34  34 (40.5)  48 (57.1)
 40-199  6   6 (7.1)  10 (11.9)
 200-999  4   4 (4.8)   5 (6.0)
 1000-9999 12  12 (14.3)   4 (4.8)
 10 000-99 999 20  20 (23.8)   1 (1.2)
 100 000+  8    8 (9.5)   5 (6.0)
 Missing  0   0 (0)  11 (13.1)
CD4 count, cells/mm3 .04
 <50  7   7 (8.3)   4 (4.8)
 50-199 21  21 (25.0)  19 (22.6)
 200-349 20  20 (23.8)  13 (15.5)
 350-499 11  11 (13.1)  13 (15.5)
 ≥500 24  24 (28.6)  24 (28.6)
 Missing  1   1 (1.2)  11 (13.1)
CD4%, cells/mm3 <.001
 <7% 14  14 (16.7)   8 (9.5)
 7%-14% 22  22 (26.2)  18 (20.2)
 15%-21% 13  13 (15.5)  14 (16.7)
 >21% 34  34 (40.5)  34 (40.5)
 Missing  1   1 (1.2)  11 (13.1)
Medication renewal, x¯ (SD) 40.91  40.91 (36.00)  80.61 (22.42) <.001
Missing 12   12 (14.3)   8 (9.5)
ID clinic visit, x¯ (SD)  1.07   1.07 (1.00)  21.5 (1.06) <.001
 Missing  8   8 (9.5)   6 (7.1)

Abbreviation: SD, standard deviation.

a

Data reflect approximately 18 months of follow-up (March 1, 2014-July 31, 2015).